The Impact of COVID-19 on Nursing Homes: Study Design and Population Description.

Vicente Rodriguez-Rodriguez, Fermina Rojo-Perez, Carmen Perez de Arenaza Escribano, María-Ángeles Molina-Martínez, Gloria Fernandez-Mayoralas, Diego Sánchez-González, Jose-Manuel Rojo-Abuin, Carmen Rodríguez-Blázquez, Maria João Forjaz, Salomé Martín García
Author Information
  1. Vicente Rodriguez-Rodriguez: Grupo de Investigacion sobre Envejecimiento (GIE), IEGD, CSIC, 28037 Madrid, Spain.
  2. Fermina Rojo-Perez: Grupo de Investigacion sobre Envejecimiento (GIE), IEGD, CSIC, 28037 Madrid, Spain. ORCID
  3. Carmen Perez de Arenaza Escribano: Grupo de Investigacion sobre Envejecimiento (GIE), IEGD, CSIC, 28037 Madrid, Spain. ORCID
  4. María-Ángeles Molina-Martínez: Departamento de Personalidad, Evaluación y Tratamiento Psicológico, Facultad de Psicología, Universidad Nacional de Educación a Distancia (UNED), 28040 Madrid, Spain.
  5. Gloria Fernandez-Mayoralas: Grupo de Investigacion sobre Envejecimiento (GIE), IEGD, CSIC, 28037 Madrid, Spain. ORCID
  6. Diego Sánchez-González: Departamento de Geografía, Universidad Nacional de Educación a Distancia (UNED), 28040 Madrid, Spain. ORCID
  7. Jose-Manuel Rojo-Abuin: Unidad de Analisis Estadistico (UAE), CCHS, CSIC, 28037 Madrid, Spain.
  8. Carmen Rodríguez-Blázquez: National Epidemiology Centre, Carlos III Institute of Health, Network Centre for Biomedical Research in Neurodegenerative Diseases (CIBERNED), 28029 Madrid, Spain. ORCID
  9. Maria João Forjaz: National Epidemiology Centre, Carlos III Institute of Health, Health Service Research Network on Chronic Diseases (REDISSEC) and Research Network on Chronicity, Primary Care and Health Promotion (RICAPPS), 28029 Madrid, Spain. ORCID
  10. Salomé Martín García: EULEN Servicios Sociosanitarios, 28023 Madrid, Spain.

Abstract

Nursing homes for the elderly in Spain have experienced high rates of infection and mortality from COVID-19, although rates have varied from one region to another. Madrid is the region where most institutionalized older adults have died from the coronavirus. However, there is little known about the psychosocial and environmental factors involved in the high incidence of COVID-19 among the institutionalised population in this region. This article describes the protocol of a study on nursing homes during the SARS-CoV-2 pandemic in the Autonomous Community of Madrid (hereafter: Region of Madrid or Madrid Region) and provides information on the study design, measures used, and characteristics of the population studied. A questionnaire about life in nursing homes during the COVID-19 pandemic was designed and a total of 447 persons over 60 years of age without cognitive impairment-220 in private nursing homes and 227 in public nursing homes-participated by answering questions about different topics: personal situations during the pandemic, feelings and methods of coping, residential environment, health, quality of life, ageism, and self-perception of ageing. The institutionalised person profile discussed in this study was an old woman, widowed, without children, with a low level of education, with multimorbidity, and who perceived her health and quality of life positively. Most of the participants were very concerned about COVID-19 and its effects. In fact, 38% had been diagnosed with COVID-19, of whom 20% were admitted to hospital and 20% had suffered negative impacts, such as pain and neurological problems. In addition, 70% of the residents remained confined to their rooms, which increased their perceptions of loneliness and social isolation. The worst-rated aspects of the nursing home resulted from the restrictive measures imposed on nursing homes during the pandemic. This research offers useful material for understanding the pandemic and its consequences from the perspective of the older institutionalised population, which could provide insights for designing public policies.

Keywords

References

  1. Rev Saude Publica. 2021 Apr 14;55:4 [PMID: 33886953]
  2. Int J Nurs Stud. 2021 Sep;121:104000 [PMID: 34242976]
  3. Lancet Psychiatry. 2020 Jun;7(6):547-560 [PMID: 32304649]
  4. Lancet Reg Health Eur. 2021 Dec;11:100261 [PMID: 34751264]
  5. J Psychiatr Res. 1982-1983;17(1):37-49 [PMID: 7183759]
  6. Aten Primaria. 2021 Dec;53 Suppl 1:102228 [PMID: 34961574]
  7. Age Ageing. 2020 Jul 1;49(4):501-515 [PMID: 32377677]
  8. Front Psychol. 2021 Jul 05;12:609967 [PMID: 34290635]
  9. J Psychiatr Res. 2021 May;137:96-103 [PMID: 33667763]
  10. Int J Nurs Stud. 2011 May;48(5):611-9 [PMID: 20947083]
  11. Public Health. 2020 Sep;186:31-34 [PMID: 32768621]
  12. Am J Public Health. 2015 May;105(5):1013-9 [PMID: 25790413]
  13. J Aging Soc Policy. 2020 Jul-Oct;32(4-5):310-315 [PMID: 32245346]
  14. J Gerontol. 1975 Jan;30(1):85-9 [PMID: 1109399]
  15. Semergen. 2020 Aug;46 Suppl 1:26-34 [PMID: 32600935]
  16. BMJ. 2020 Apr 20;369:m1554 [PMID: 32312710]
  17. J Am Med Dir Assoc. 2021 May;22(5):948-954.e2 [PMID: 33861980]
  18. Age Ageing. 2020 Aug 24;49(5):692-695 [PMID: 32377666]
  19. Aten Primaria. 2020 Aug-Sep;52(7):515-516 [PMID: 32425290]
  20. Glob Health Res Policy. 2020 Jun 5;5:27 [PMID: 32514427]
  21. Int J Ment Health Addict. 2022;20(3):1537-1545 [PMID: 32226353]
  22. EClinicalMedicine. 2021 Mar;33:100771 [PMID: 33681730]
  23. J Am Med Dir Assoc. 2020 Nov;21(11):1568-1569 [PMID: 33138939]
  24. Geriatr Nurs. 2021 Nov-Dec;42(6):1422-1428 [PMID: 34638056]
  25. Rev Clin Esp. 2020 Jun 26;: [PMID: 32680592]
  26. Front Psychiatry. 2020 Nov 17;11:585813 [PMID: 33281646]
  27. J Pers Soc Psychol. 1988 Jun;54(6):1063-70 [PMID: 3397865]
  28. J Aging Soc Policy. 2020 Jul-Oct;32(4-5):410-415 [PMID: 32441209]
  29. Gerontologist. 1969 Winter;9(4):243-6 [PMID: 5366225]
  30. BMJ. 2020 Apr 14;369:m1465 [PMID: 32291259]
  31. Asian J Psychiatr. 2020 Jun;51:102092 [PMID: 32315963]
  32. PLoS One. 2020 Nov 5;15(11):e0241826 [PMID: 33152034]
  33. Rev Med Chil. 2020 Aug;148(8):1139-1154 [PMID: 33399781]
  34. Scientometrics. 2020;125(1):795-812 [PMID: 32836530]
  35. J Nutr Health Aging. 2020;24(9):938-947 [PMID: 33155618]
  36. Aging Ment Health. 2015;19(11):1031-41 [PMID: 25584744]
  37. J Gerontol A Biol Sci Med Sci. 2020 Sep 16;75(9):e123-e125 [PMID: 32307522]
  38. Sci Rep. 2021 Jun 15;11(1):12530 [PMID: 34131216]
  39. J Pers Assess. 1978 Jun;42(3):290-4 [PMID: 660402]
  40. PLoS One. 2021 Mar 26;16(3):e0249098 [PMID: 33770110]
  41. Int Psychogeriatr. 2020 Nov;32(11):1345-1352 [PMID: 32389141]
  42. J Am Geriatr Soc. 1999 Jul;47(7):873-8 [PMID: 10404935]
  43. Rev Esp Geriatr Gerontol. 2020 Sep - Oct;55(5):249-252 [PMID: 32741601]
  44. Actas Esp Psiquiatr. 2021 May;49(3):96-105 [PMID: 33969469]
  45. Int J Nurs Stud Adv. 2021 Nov;3:100031 [PMID: 34095858]
  46. Front Public Health. 2021 Jul 14;9:659263 [PMID: 34336761]
  47. Gac Sanit. 2022 Jan-Feb;36(1):3-5 [PMID: 34400008]
  48. Ir Med J. 2020 Apr 03;113(4):50 [PMID: 32268044]
  49. J Adv Nurs. 1992 Jan;17(1):43-51 [PMID: 1537989]
  50. Gerontologist. 2020 Jan 24;60(1):174-181 [PMID: 30423119]
  51. Rev Esp Geriatr Gerontol. 2021 Jul-Aug;56(4):208-217 [PMID: 33892992]
  52. Infect Control Hosp Epidemiol. 2022 Apr;43(4):504-509 [PMID: 33100245]
  53. J Gerontol A Biol Sci Med Sci. 2020 Sep 16;75(9):e126-e127 [PMID: 32314784]
  54. Lancet Psychiatry. 2020 May;7(5):387-388 [PMID: 32353267]
  55. J Psychiatr Res. 2021 Apr;136:103-108 [PMID: 33582608]
  56. Rev Clin Esp. 2007 Dec;207(11):559-62 [PMID: 18021644]
  57. Rev Esp Geriatr Gerontol. 2020 Sep - Oct;55(5):266-271 [PMID: 32718581]
  58. J Am Geriatr Soc. 2020 Jun;68(6):E27-E29 [PMID: 32359072]
  59. Arch Gerontol Geriatr. 2002 Nov-Dec;35(3):261-74 [PMID: 14764365]
  60. Int J Environ Res Public Health. 2021 Sep 26;18(19): [PMID: 34639401]
  61. Geriatr Nurs. 2021 Sep-Oct;42(5):1222-1229 [PMID: 33824008]
  62. BMC Med Res Methodol. 2021 Apr 23;21(1):82 [PMID: 33892631]
  63. Health Qual Life Outcomes. 2016 Jan 28;14:16 [PMID: 26821587]
  64. Front Psychiatry. 2021 Sep 07;12:708430 [PMID: 34557117]
  65. Assessment. 2004 Mar;11(1):94-101 [PMID: 14994958]
  66. Span J Psychol. 2015 Mar 03;18:E3 [PMID: 26054863]

MeSH Term

Humans
Female
Child
Aged
Middle Aged
COVID-19
Homes for the Aged
Quality of Life
SARS-CoV-2
Pandemics
Nursing Homes

Word Cloud

Created with Highcharts 10.0.0COVID-19nursinghomespandemicMadridlifehealthregioninstitutionalisedpopulationstudyqualityNursinghighratesolderRegionmeasureswithoutpublicfeelingscopingresidentialenvironmentageism20%elderlySpainexperiencedinfectionmortalityalthoughvariedoneanotherinstitutionalizedadultsdiedcoronavirusHoweverlittleknownpsychosocialenvironmentalfactorsinvolvedincidenceamongarticledescribesprotocolSARS-CoV-2AutonomousCommunityhereafter:providesinformationdesignusedcharacteristicsstudiedquestionnairedesignedtotal447persons60yearsagecognitiveimpairment-220private227homes-participatedansweringquestionsdifferenttopics:personalsituationsmethodsself-perceptionageingpersonprofilediscussedoldwomanwidowedchildrenlowleveleducationmultimorbidityperceivedpositivelyparticipantsconcernedeffectsfact38%diagnosedadmittedhospitalsufferednegativeimpactspainneurologicalproblemsaddition70%residentsremainedconfinedroomsincreasedperceptionslonelinesssocialisolationworst-ratedaspectshomeresultedrestrictiveimposedresearchoffersusefulmaterialunderstandingconsequencesperspectiveprovideinsightsdesigningpoliciesImpactHomes:StudyDesignPopulationDescriptionmentalperceptionphysical

Similar Articles

Cited By